SlideShare a Scribd company logo
SYMPATHOMIMETICS/ ADRENERGIC
DRUGS: CLASSIFICATION AND SAR
ACCORDING TO CHEMICAL NATURE
 Catecholamines: possess catechol nucleus
e.g. Adrenaline, Nor-Adr, Dopamine
 Non-catecholamines: no catechol nucleus
e.g. Ephedrine, Metaraminol
ACCORDING TO MODE OF ACTION
 Direct acting: Act directly on receptors.
E.g. Adr, Nor-Adr, Isoprenaline and Salbutamol
 Indirect acting: Act on adrenergic neurons to release Nor-Adr.
E.g. Tyramine, Amphetamine.
 Mixed acting: Can act in both ways. E.g. Ephedrine
ACCORDING TO RECEPTOR SELECTIVITY
 α1 selective: Phenyl ephrine
 α2 selective: Clonidine
 Both α1 and α2 selective: Adr and Nor Adr
 β1 selective: Dobutamine
 β2 selective: Salbutamol
 Both β1 and β2 selective: Adr, Nor Adr, Isoproterenol
ACCORDING TO THERAPEUTIC EFFECT
 Vasoconstrictor: Adr, Nor-Adr, Ephedrine, Phenylephrine
 Bronchodilator: Salbutamol, Terbutaline, Isoprenaline
 Cardiac stimulant: Adr, Isoprenaline
 CNS stimulant: Amphetamine, Methamphetamine
 Nasal decongestant: Ephedrine, Naphazoline, Oxymetazoline,
Xylometazoline
 Anorectics- Fenfluramine, Sibutramine (But banned due to serious side
effects like heart attack)
ADRENORECEPTORS
 G-protein coupled receptor.
 Located throughout the body on neuronal and non-
neuronal tissues.
 2 types- α and β receptors
 α receptor is further of 2 subtypes – α1 and α2
 β receptor is further of 3 subtypes –β1, β2 and β3
ADRENORECEPTOR, DISTRIBUTION, ACTION
Receptor Location Action Use Agonist Antagonis
t
α1
Blood
vessels
Contraction Hypotension,
Shock Phenylephrin
e
Prazosin
(Antihypert
ensive)
Eye Dilation Mydriatics
Mucus
memb
Vasoconstriction Nasal
decongestant
Prostate
gland
Contraction
α2 CNS Decrease
neurotransmitter
release
Antihypertens
ive Clonidine
(Antihyperten
sive)
Yohimbine
Pancreatic
cells
Decrease insulin
release
Receptor Location Action Use Agonist Antagonist
β1
Heart
muscle
Muscle contraction Increase
heart rate
and force Dobutamine Metoprolol
(Antihyperte
nsive)
Kidney Increase renin
secretion
Increase
BP
β2 Smooth
muscle
(Bronchus)
Relaxation
(Bronchodialation)
Asthma
and COPD
Salbutamol Butoxamine
β3 Adipose
tissue
Lipolysis BRL 37344
SAR OF SYMPATHOMIMETIC DRUGS
 Parent structure of most of adrenergic drugs is β-phenylethylamine.
 Modifications of β-phenylethylamine influence not only the mechanism
of action, the receptor selectivity, but also their absorption, oral
activity, metabolism, and thus duration of action (DOA).
 For the direct-acting sympathomimetic amines, maximal activity is
seen in β-phenylethylamine derivatives containing
 (a) catechol
 (b) OH group on the ethylamine portion of the molecule.
 High adrenergic activity occurs when two carbon atoms separate the
aromatic ring from the amino group.
 Primary and secondary amines have good adrenergic activity, whereas
tertiary amines and quaternary ammonium salts do not.
 The nature of the amino substituent also affects the receptor selectivity of
the compound. As the size of the nitrogen substituent increases, α-receptor
agonist activity generally decreases and β-receptor agonist activity
increases.
 Substitution by small alkyl group at α- carbon (e.g., CH3- or C2H5-) slows
metabolism by MAO. So, addition of small alkyl group increases the
resistance to metabolism and lipophilicity, so such compounds often exhibit
enhanced oral effectiveness and greater CNS activity than other compounds
that do not contain an α-alkyl group.
 Substitution at β- C by OH greatly enhances agonist activity at both α- and
β-receptors.
 Compounds with 3,4-dihydroxy group in phenyl nucleus act as direct acting
drugs whereas without catechol nucleus act as indirect acting drugs.
 Compounds without one or both phenolic OH substituents are not
metabolized by COMT, and they are orally active and have longer duration
of action.

More Related Content

What's hot

Anticholinergics Med Chem Lecture
Anticholinergics Med Chem LectureAnticholinergics Med Chem Lecture
Anticholinergics Med Chem Lecture
sagar joshi
 
Sympathomimetic agents: SAR of Sympathomimetic agents
Sympathomimetic agents: SAR of Sympathomimetic agentsSympathomimetic agents: SAR of Sympathomimetic agents
Sympathomimetic agents: SAR of Sympathomimetic agents
Subham Kumar Vishwakarma
 
General Anaesthesia (Medicinal Chemistry)
General Anaesthesia (Medicinal Chemistry)General Anaesthesia (Medicinal Chemistry)
General Anaesthesia (Medicinal Chemistry)
Yogesh Tiwari
 
Medicinal chemistry adrenergic agonists
Medicinal chemistry adrenergic agonistsMedicinal chemistry adrenergic agonists
Medicinal chemistry adrenergic agonists
kencha swathi
 
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
kencha swathi
 
Medicinal chemistry unit-5 ,4th semester
Medicinal chemistry unit-5 ,4th semesterMedicinal chemistry unit-5 ,4th semester
Medicinal chemistry unit-5 ,4th semester
snigdharanibehera
 
PARASYMPATHOMIMETIC DRUGS Classification and SAR.pptx
PARASYMPATHOMIMETIC DRUGS Classification and SAR.pptxPARASYMPATHOMIMETIC DRUGS Classification and SAR.pptx
PARASYMPATHOMIMETIC DRUGS Classification and SAR.pptx
Jasmine Chaudhary
 
Cholinergic agent
Cholinergic agentCholinergic agent
Cholinergic agent
ASHOK GAUTAM
 
Synthesis of some important drugs
Synthesis of some important drugsSynthesis of some important drugs
Synthesis of some important drugs
Khan Firoz
 
Antipsychotic agents (1)
Antipsychotic agents (1)Antipsychotic agents (1)
Antipsychotic agents (1)
Priya Hargunani
 
Non-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal Chemistry
Non-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal ChemistryNon-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal Chemistry
Non-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal Chemistry
Dr. Gopal Krishna Padhy
 
Narcotic & non narcotic analgesic
Narcotic & non narcotic analgesicNarcotic & non narcotic analgesic
Narcotic & non narcotic analgesic
SKarthigaSVCP
 
Barbiturates
BarbituratesBarbiturates
Barbiturates
Manoj Munde
 
Adrenergic Drugs synthesis
Adrenergic Drugs synthesisAdrenergic Drugs synthesis
Adrenergic Drugs synthesis
DrParthiban1
 
Practical Experiment 6: To synthesize and characterized 2,3 diphenyl quninox...
Practical Experiment 6: To synthesize and characterized 2,3  diphenyl quninox...Practical Experiment 6: To synthesize and characterized 2,3  diphenyl quninox...
Practical Experiment 6: To synthesize and characterized 2,3 diphenyl quninox...
SONALI PAWAR
 
Sympathomimmetic agents
Sympathomimmetic agentsSympathomimmetic agents
Sympathomimmetic agents
Rajkumar Kumawat
 
Unit 4 Pyrazole
Unit 4 PyrazoleUnit 4 Pyrazole
Unit 4 Pyrazole
Sowmiya Perinbaraj
 
Reactions of chiral molecules
Reactions  of  chiral  moleculesReactions  of  chiral  molecules
Reactions of chiral molecules
Drx Mathivanan Selvam
 
General anaesthetics
General anaestheticsGeneral anaesthetics
General anaesthetics
kencha swathi
 
Sedative Med Chem Lecture
Sedative Med Chem Lecture Sedative Med Chem Lecture
Sedative Med Chem Lecture
sagar joshi
 

What's hot (20)

Anticholinergics Med Chem Lecture
Anticholinergics Med Chem LectureAnticholinergics Med Chem Lecture
Anticholinergics Med Chem Lecture
 
Sympathomimetic agents: SAR of Sympathomimetic agents
Sympathomimetic agents: SAR of Sympathomimetic agentsSympathomimetic agents: SAR of Sympathomimetic agents
Sympathomimetic agents: SAR of Sympathomimetic agents
 
General Anaesthesia (Medicinal Chemistry)
General Anaesthesia (Medicinal Chemistry)General Anaesthesia (Medicinal Chemistry)
General Anaesthesia (Medicinal Chemistry)
 
Medicinal chemistry adrenergic agonists
Medicinal chemistry adrenergic agonistsMedicinal chemistry adrenergic agonists
Medicinal chemistry adrenergic agonists
 
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
 
Medicinal chemistry unit-5 ,4th semester
Medicinal chemistry unit-5 ,4th semesterMedicinal chemistry unit-5 ,4th semester
Medicinal chemistry unit-5 ,4th semester
 
PARASYMPATHOMIMETIC DRUGS Classification and SAR.pptx
PARASYMPATHOMIMETIC DRUGS Classification and SAR.pptxPARASYMPATHOMIMETIC DRUGS Classification and SAR.pptx
PARASYMPATHOMIMETIC DRUGS Classification and SAR.pptx
 
Cholinergic agent
Cholinergic agentCholinergic agent
Cholinergic agent
 
Synthesis of some important drugs
Synthesis of some important drugsSynthesis of some important drugs
Synthesis of some important drugs
 
Antipsychotic agents (1)
Antipsychotic agents (1)Antipsychotic agents (1)
Antipsychotic agents (1)
 
Non-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal Chemistry
Non-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal ChemistryNon-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal Chemistry
Non-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal Chemistry
 
Narcotic & non narcotic analgesic
Narcotic & non narcotic analgesicNarcotic & non narcotic analgesic
Narcotic & non narcotic analgesic
 
Barbiturates
BarbituratesBarbiturates
Barbiturates
 
Adrenergic Drugs synthesis
Adrenergic Drugs synthesisAdrenergic Drugs synthesis
Adrenergic Drugs synthesis
 
Practical Experiment 6: To synthesize and characterized 2,3 diphenyl quninox...
Practical Experiment 6: To synthesize and characterized 2,3  diphenyl quninox...Practical Experiment 6: To synthesize and characterized 2,3  diphenyl quninox...
Practical Experiment 6: To synthesize and characterized 2,3 diphenyl quninox...
 
Sympathomimmetic agents
Sympathomimmetic agentsSympathomimmetic agents
Sympathomimmetic agents
 
Unit 4 Pyrazole
Unit 4 PyrazoleUnit 4 Pyrazole
Unit 4 Pyrazole
 
Reactions of chiral molecules
Reactions  of  chiral  moleculesReactions  of  chiral  molecules
Reactions of chiral molecules
 
General anaesthetics
General anaestheticsGeneral anaesthetics
General anaesthetics
 
Sedative Med Chem Lecture
Sedative Med Chem Lecture Sedative Med Chem Lecture
Sedative Med Chem Lecture
 

Similar to Sympathomimetics Classification and SAR.ppt

Leedsphcem ADRENERGIC AGENTS
Leedsphcem ADRENERGIC AGENTSLeedsphcem ADRENERGIC AGENTS
Leedsphcem ADRENERGIC AGENTS
Duane Goodman
 
Adrenergic and anti-adrenergic agents
Adrenergic and anti-adrenergic agentsAdrenergic and anti-adrenergic agents
Adrenergic and anti-adrenergic agents
TanviGoel25
 
adrenergic agents
adrenergic agentsadrenergic agents
adrenergic agents
Leeds Francisco
 
adrenergicdrugs-181220100636 (1).pptx
adrenergicdrugs-181220100636 (1).pptxadrenergicdrugs-181220100636 (1).pptx
adrenergicdrugs-181220100636 (1).pptx
Elvis329271
 
Adrenergic drugs
Adrenergic drugsAdrenergic drugs
Adrenergic drugs
Shalini jaswal
 
Adrenergic blockers
Adrenergic blockersAdrenergic blockers
Adrenergic blockers
Sahil Patil
 
SYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdf
SYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdfSYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdf
SYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdf
Professor Afzal Basha Shaik
 
Adrenergic_agonist_antagonist
Adrenergic_agonist_antagonistAdrenergic_agonist_antagonist
Adrenergic_agonist_antagonist
Suman Bhattarai
 
Drugs acting on Autonomic Nervous System / Sympathomimetic drugs (Adrenergic...
Drugs acting on  Autonomic Nervous System / Sympathomimetic drugs (Adrenergic...Drugs acting on  Autonomic Nervous System / Sympathomimetic drugs (Adrenergic...
Drugs acting on Autonomic Nervous System / Sympathomimetic drugs (Adrenergic...
Mr.S.SEETARAM SWAMY
 
16255781.ppt
16255781.ppt16255781.ppt
16255781.ppt
Fahdnaif2
 
Barbiturates
BarbituratesBarbiturates
Barbiturates
Khalid Hussain
 
Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...
Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...
Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...
Ahmad Naeem
 
Adrenergic agents lady ann
Adrenergic agents   lady annAdrenergic agents   lady ann
Adrenergic agents lady ann
Leeds Francisco
 
Protein metabolism
Protein metabolismProtein metabolism
Protein metabolism
enamifat
 
Systemic Pharmacology Of Autonomic Nervous System. Sympathomimetics Agents
Systemic Pharmacology Of Autonomic Nervous System. Sympathomimetics AgentsSystemic Pharmacology Of Autonomic Nervous System. Sympathomimetics Agents
Systemic Pharmacology Of Autonomic Nervous System. Sympathomimetics Agents
Ashish Gadage
 
Characteristics and Properties of Amino Acids (AA)
Characteristics and Properties of Amino Acids (AA)Characteristics and Properties of Amino Acids (AA)
Characteristics and Properties of Amino Acids (AA)
Mohamed Hassanien
 
classification adrenergic.pdf of automatic nervous system
classification adrenergic.pdf of automatic nervous systemclassification adrenergic.pdf of automatic nervous system
classification adrenergic.pdf of automatic nervous system
MuhammadAhmad135526
 
ANTI-HYPERTENSIVE%20DRUGS%20123.pptx
ANTI-HYPERTENSIVE%20DRUGS%20123.pptxANTI-HYPERTENSIVE%20DRUGS%20123.pptx
ANTI-HYPERTENSIVE%20DRUGS%20123.pptx
Amrita Vshwavidyapeetham , Amrita School Of Pharmacy
 
Adrenergic Drugs II
Adrenergic Drugs IIAdrenergic Drugs II
Adrenergic Drugs II
coolboy101pk
 
Opoid analgesics
Opoid analgesics Opoid analgesics
Opoid analgesics
Sudam Mule
 

Similar to Sympathomimetics Classification and SAR.ppt (20)

Leedsphcem ADRENERGIC AGENTS
Leedsphcem ADRENERGIC AGENTSLeedsphcem ADRENERGIC AGENTS
Leedsphcem ADRENERGIC AGENTS
 
Adrenergic and anti-adrenergic agents
Adrenergic and anti-adrenergic agentsAdrenergic and anti-adrenergic agents
Adrenergic and anti-adrenergic agents
 
adrenergic agents
adrenergic agentsadrenergic agents
adrenergic agents
 
adrenergicdrugs-181220100636 (1).pptx
adrenergicdrugs-181220100636 (1).pptxadrenergicdrugs-181220100636 (1).pptx
adrenergicdrugs-181220100636 (1).pptx
 
Adrenergic drugs
Adrenergic drugsAdrenergic drugs
Adrenergic drugs
 
Adrenergic blockers
Adrenergic blockersAdrenergic blockers
Adrenergic blockers
 
SYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdf
SYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdfSYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdf
SYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdf
 
Adrenergic_agonist_antagonist
Adrenergic_agonist_antagonistAdrenergic_agonist_antagonist
Adrenergic_agonist_antagonist
 
Drugs acting on Autonomic Nervous System / Sympathomimetic drugs (Adrenergic...
Drugs acting on  Autonomic Nervous System / Sympathomimetic drugs (Adrenergic...Drugs acting on  Autonomic Nervous System / Sympathomimetic drugs (Adrenergic...
Drugs acting on Autonomic Nervous System / Sympathomimetic drugs (Adrenergic...
 
16255781.ppt
16255781.ppt16255781.ppt
16255781.ppt
 
Barbiturates
BarbituratesBarbiturates
Barbiturates
 
Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...
Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...
Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...
 
Adrenergic agents lady ann
Adrenergic agents   lady annAdrenergic agents   lady ann
Adrenergic agents lady ann
 
Protein metabolism
Protein metabolismProtein metabolism
Protein metabolism
 
Systemic Pharmacology Of Autonomic Nervous System. Sympathomimetics Agents
Systemic Pharmacology Of Autonomic Nervous System. Sympathomimetics AgentsSystemic Pharmacology Of Autonomic Nervous System. Sympathomimetics Agents
Systemic Pharmacology Of Autonomic Nervous System. Sympathomimetics Agents
 
Characteristics and Properties of Amino Acids (AA)
Characteristics and Properties of Amino Acids (AA)Characteristics and Properties of Amino Acids (AA)
Characteristics and Properties of Amino Acids (AA)
 
classification adrenergic.pdf of automatic nervous system
classification adrenergic.pdf of automatic nervous systemclassification adrenergic.pdf of automatic nervous system
classification adrenergic.pdf of automatic nervous system
 
ANTI-HYPERTENSIVE%20DRUGS%20123.pptx
ANTI-HYPERTENSIVE%20DRUGS%20123.pptxANTI-HYPERTENSIVE%20DRUGS%20123.pptx
ANTI-HYPERTENSIVE%20DRUGS%20123.pptx
 
Adrenergic Drugs II
Adrenergic Drugs IIAdrenergic Drugs II
Adrenergic Drugs II
 
Opoid analgesics
Opoid analgesics Opoid analgesics
Opoid analgesics
 

More from Jasmine Chaudhary

Antacids.pdf
Antacids.pdfAntacids.pdf
Antacids.pdf
Jasmine Chaudhary
 
Non-aq. Titration.pdf
Non-aq. Titration.pdfNon-aq. Titration.pdf
Non-aq. Titration.pdf
Jasmine Chaudhary
 
Oral Hypoglycemic Agent (1).pdf
Oral Hypoglycemic Agent (1).pdfOral Hypoglycemic Agent (1).pdf
Oral Hypoglycemic Agent (1).pdf
Jasmine Chaudhary
 
Insulin.pdf
Insulin.pdfInsulin.pdf
Insulin.pdf
Jasmine Chaudhary
 
Fundamentals of Volumetric Analysis.pdf
Fundamentals of Volumetric Analysis.pdfFundamentals of Volumetric Analysis.pdf
Fundamentals of Volumetric Analysis.pdf
Jasmine Chaudhary
 
Progesterone.pdf
Progesterone.pdfProgesterone.pdf
Progesterone.pdf
Jasmine Chaudhary
 
Estrogen.pdf
Estrogen.pdfEstrogen.pdf
Estrogen.pdf
Jasmine Chaudhary
 
Testosterone.pdf
Testosterone.pdfTestosterone.pdf
Testosterone.pdf
Jasmine Chaudhary
 
Steroids Nomenclature.pdf
Steroids Nomenclature.pdfSteroids Nomenclature.pdf
Steroids Nomenclature.pdf
Jasmine Chaudhary
 
Antianginal Drugs.pdf
Antianginal Drugs.pdfAntianginal Drugs.pdf
Antianginal Drugs.pdf
Jasmine Chaudhary
 
Primary and Secondary standards.pdf
Primary and Secondary standards.pdfPrimary and Secondary standards.pdf
Primary and Secondary standards.pdf
Jasmine Chaudhary
 
Antihyperlipidemic.pdf
Antihyperlipidemic.pdfAntihyperlipidemic.pdf
Antihyperlipidemic.pdf
Jasmine Chaudhary
 
Antihypertensive Drugs.pdf
Antihypertensive Drugs.pdfAntihypertensive Drugs.pdf
Antihypertensive Drugs.pdf
Jasmine Chaudhary
 
Errors in Pharmaceutical analysis.pdf
Errors in Pharmaceutical analysis.pdfErrors in Pharmaceutical analysis.pdf
Errors in Pharmaceutical analysis.pdf
Jasmine Chaudhary
 
ANTICANCER- Part II.pptx
ANTICANCER- Part II.pptxANTICANCER- Part II.pptx
ANTICANCER- Part II.pptx
Jasmine Chaudhary
 
ANTICANCER.pdf
ANTICANCER.pdfANTICANCER.pdf
ANTICANCER.pdf
Jasmine Chaudhary
 
H2 antagonist.pdf
H2 antagonist.pdfH2 antagonist.pdf
H2 antagonist.pdf
Jasmine Chaudhary
 
Histamine.pdf
Histamine.pdfHistamine.pdf
Histamine.pdf
Jasmine Chaudhary
 
Adrenoreceptor Blockers.pdf
Adrenoreceptor Blockers.pdfAdrenoreceptor Blockers.pdf
Adrenoreceptor Blockers.pdf
Jasmine Chaudhary
 
Sympathomimetic Drugs.ppt
Sympathomimetic Drugs.pptSympathomimetic Drugs.ppt
Sympathomimetic Drugs.ppt
Jasmine Chaudhary
 

More from Jasmine Chaudhary (20)

Antacids.pdf
Antacids.pdfAntacids.pdf
Antacids.pdf
 
Non-aq. Titration.pdf
Non-aq. Titration.pdfNon-aq. Titration.pdf
Non-aq. Titration.pdf
 
Oral Hypoglycemic Agent (1).pdf
Oral Hypoglycemic Agent (1).pdfOral Hypoglycemic Agent (1).pdf
Oral Hypoglycemic Agent (1).pdf
 
Insulin.pdf
Insulin.pdfInsulin.pdf
Insulin.pdf
 
Fundamentals of Volumetric Analysis.pdf
Fundamentals of Volumetric Analysis.pdfFundamentals of Volumetric Analysis.pdf
Fundamentals of Volumetric Analysis.pdf
 
Progesterone.pdf
Progesterone.pdfProgesterone.pdf
Progesterone.pdf
 
Estrogen.pdf
Estrogen.pdfEstrogen.pdf
Estrogen.pdf
 
Testosterone.pdf
Testosterone.pdfTestosterone.pdf
Testosterone.pdf
 
Steroids Nomenclature.pdf
Steroids Nomenclature.pdfSteroids Nomenclature.pdf
Steroids Nomenclature.pdf
 
Antianginal Drugs.pdf
Antianginal Drugs.pdfAntianginal Drugs.pdf
Antianginal Drugs.pdf
 
Primary and Secondary standards.pdf
Primary and Secondary standards.pdfPrimary and Secondary standards.pdf
Primary and Secondary standards.pdf
 
Antihyperlipidemic.pdf
Antihyperlipidemic.pdfAntihyperlipidemic.pdf
Antihyperlipidemic.pdf
 
Antihypertensive Drugs.pdf
Antihypertensive Drugs.pdfAntihypertensive Drugs.pdf
Antihypertensive Drugs.pdf
 
Errors in Pharmaceutical analysis.pdf
Errors in Pharmaceutical analysis.pdfErrors in Pharmaceutical analysis.pdf
Errors in Pharmaceutical analysis.pdf
 
ANTICANCER- Part II.pptx
ANTICANCER- Part II.pptxANTICANCER- Part II.pptx
ANTICANCER- Part II.pptx
 
ANTICANCER.pdf
ANTICANCER.pdfANTICANCER.pdf
ANTICANCER.pdf
 
H2 antagonist.pdf
H2 antagonist.pdfH2 antagonist.pdf
H2 antagonist.pdf
 
Histamine.pdf
Histamine.pdfHistamine.pdf
Histamine.pdf
 
Adrenoreceptor Blockers.pdf
Adrenoreceptor Blockers.pdfAdrenoreceptor Blockers.pdf
Adrenoreceptor Blockers.pdf
 
Sympathomimetic Drugs.ppt
Sympathomimetic Drugs.pptSympathomimetic Drugs.ppt
Sympathomimetic Drugs.ppt
 

Recently uploaded

Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
amberjdewit93
 
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptxBeyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
EduSkills OECD
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
GeorgeMilliken2
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
Priyankaranawat4
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
Nicholas Montgomery
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
Dr. Shivangi Singh Parihar
 
Advanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docxAdvanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docx
adhitya5119
 
How to Create a More Engaging and Human Online Learning Experience
How to Create a More Engaging and Human Online Learning Experience How to Create a More Engaging and Human Online Learning Experience
How to Create a More Engaging and Human Online Learning Experience
Wahiba Chair Training & Consulting
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
Israel Genealogy Research Association
 
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective UpskillingYour Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Excellence Foundation for South Sudan
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
Priyankaranawat4
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
Colégio Santa Teresinha
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
National Information Standards Organization (NISO)
 
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
Nguyen Thanh Tu Collection
 
Main Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docxMain Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docx
adhitya5119
 
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdfবাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
eBook.com.bd (প্রয়োজনীয় বাংলা বই)
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
History of Stoke Newington
 
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skillsspot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
haiqairshad
 
How to deliver Powerpoint Presentations.pptx
How to deliver Powerpoint  Presentations.pptxHow to deliver Powerpoint  Presentations.pptx
How to deliver Powerpoint Presentations.pptx
HajraNaeem15
 

Recently uploaded (20)

Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
 
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptxBeyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
 
Advanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docxAdvanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docx
 
How to Create a More Engaging and Human Online Learning Experience
How to Create a More Engaging and Human Online Learning Experience How to Create a More Engaging and Human Online Learning Experience
How to Create a More Engaging and Human Online Learning Experience
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
 
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective UpskillingYour Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective Upskilling
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
 
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
 
Main Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docxMain Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docx
 
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdfবাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
 
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skillsspot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
 
How to deliver Powerpoint Presentations.pptx
How to deliver Powerpoint  Presentations.pptxHow to deliver Powerpoint  Presentations.pptx
How to deliver Powerpoint Presentations.pptx
 

Sympathomimetics Classification and SAR.ppt

  • 2. ACCORDING TO CHEMICAL NATURE  Catecholamines: possess catechol nucleus e.g. Adrenaline, Nor-Adr, Dopamine  Non-catecholamines: no catechol nucleus e.g. Ephedrine, Metaraminol
  • 3. ACCORDING TO MODE OF ACTION  Direct acting: Act directly on receptors. E.g. Adr, Nor-Adr, Isoprenaline and Salbutamol  Indirect acting: Act on adrenergic neurons to release Nor-Adr. E.g. Tyramine, Amphetamine.  Mixed acting: Can act in both ways. E.g. Ephedrine
  • 4. ACCORDING TO RECEPTOR SELECTIVITY  α1 selective: Phenyl ephrine  α2 selective: Clonidine  Both α1 and α2 selective: Adr and Nor Adr
  • 5.  β1 selective: Dobutamine  β2 selective: Salbutamol  Both β1 and β2 selective: Adr, Nor Adr, Isoproterenol
  • 6. ACCORDING TO THERAPEUTIC EFFECT  Vasoconstrictor: Adr, Nor-Adr, Ephedrine, Phenylephrine  Bronchodilator: Salbutamol, Terbutaline, Isoprenaline  Cardiac stimulant: Adr, Isoprenaline  CNS stimulant: Amphetamine, Methamphetamine  Nasal decongestant: Ephedrine, Naphazoline, Oxymetazoline, Xylometazoline  Anorectics- Fenfluramine, Sibutramine (But banned due to serious side effects like heart attack)
  • 7. ADRENORECEPTORS  G-protein coupled receptor.  Located throughout the body on neuronal and non- neuronal tissues.  2 types- α and β receptors  α receptor is further of 2 subtypes – α1 and α2  β receptor is further of 3 subtypes –β1, β2 and β3
  • 8. ADRENORECEPTOR, DISTRIBUTION, ACTION Receptor Location Action Use Agonist Antagonis t α1 Blood vessels Contraction Hypotension, Shock Phenylephrin e Prazosin (Antihypert ensive) Eye Dilation Mydriatics Mucus memb Vasoconstriction Nasal decongestant Prostate gland Contraction α2 CNS Decrease neurotransmitter release Antihypertens ive Clonidine (Antihyperten sive) Yohimbine Pancreatic cells Decrease insulin release
  • 9. Receptor Location Action Use Agonist Antagonist β1 Heart muscle Muscle contraction Increase heart rate and force Dobutamine Metoprolol (Antihyperte nsive) Kidney Increase renin secretion Increase BP β2 Smooth muscle (Bronchus) Relaxation (Bronchodialation) Asthma and COPD Salbutamol Butoxamine β3 Adipose tissue Lipolysis BRL 37344
  • 10. SAR OF SYMPATHOMIMETIC DRUGS  Parent structure of most of adrenergic drugs is β-phenylethylamine.  Modifications of β-phenylethylamine influence not only the mechanism of action, the receptor selectivity, but also their absorption, oral activity, metabolism, and thus duration of action (DOA).  For the direct-acting sympathomimetic amines, maximal activity is seen in β-phenylethylamine derivatives containing  (a) catechol  (b) OH group on the ethylamine portion of the molecule.
  • 11.  High adrenergic activity occurs when two carbon atoms separate the aromatic ring from the amino group.  Primary and secondary amines have good adrenergic activity, whereas tertiary amines and quaternary ammonium salts do not.  The nature of the amino substituent also affects the receptor selectivity of the compound. As the size of the nitrogen substituent increases, α-receptor agonist activity generally decreases and β-receptor agonist activity increases.  Substitution by small alkyl group at α- carbon (e.g., CH3- or C2H5-) slows metabolism by MAO. So, addition of small alkyl group increases the resistance to metabolism and lipophilicity, so such compounds often exhibit enhanced oral effectiveness and greater CNS activity than other compounds that do not contain an α-alkyl group.  Substitution at β- C by OH greatly enhances agonist activity at both α- and β-receptors.
  • 12.  Compounds with 3,4-dihydroxy group in phenyl nucleus act as direct acting drugs whereas without catechol nucleus act as indirect acting drugs.  Compounds without one or both phenolic OH substituents are not metabolized by COMT, and they are orally active and have longer duration of action.